Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 451

1.

Idarubicin, cytarabine, and nivolumab in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a single-arm, phase 2 study.

Ravandi F, Assi R, Daver N, Benton CB, Kadia T, Thompson PA, Borthakur G, Alvarado Y, Jabbour EJ, Konopleva M, Takahashi K, Kornblau S, DiNardo CD, Estrov Z, Flores W, Basu S, Allison J, Sharma P, Pierce S, Pike A, Cortes JE, Garcia-Manero G, Kantarjian HM.

Lancet Haematol. 2019 Sep;6(9):e480-e488. doi: 10.1016/S2352-3026(19)30114-0. Epub 2019 Aug 7.

PMID:
31400961
2.

The landscape of genetic mutations in patients with chronic lymphocytic leukaemia and complex karyotype.

Strati P, Wang F, Tambaro FP, Thompson PA, Burger JA, Jain N, Ferrajoli A, Bose P, Estrov Z, Keating MJ, Futreal A, Takahashi K, Wierda WG.

Br J Haematol. 2019 Jul 25. doi: 10.1111/bjh.16117. [Epub ahead of print] No abstract available.

PMID:
31344256
3.

Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL.

Strati P, Takahashi K, Peterson CB, Keating MJ, Thompson PA, Daver NG, Jain N, Burger JA, Estrov Z, O'Brien SM, Kantarjian HM, Wierda WG, Futreal PA, Ferrajoli A.

Blood Adv. 2019 May 14;3(9):1533-1539. doi: 10.1182/bloodadvances.2019031336.

4.

Testing the unitary theory of language lateralization using functional transcranial Doppler sonography in adults.

Woodhead ZVJ, Bradshaw AR, Wilson AC, Thompson PA, Bishop DVM.

R Soc Open Sci. 2019 Mar 13;6(3):181801. doi: 10.1098/rsos.181801. eCollection 2019 Mar.

5.

Selenium supplementation and insulin resistance in a randomized, clinical trial.

Jacobs ET, Lance P, Mandarino LJ, Ellis NA, Chow HS, Foote J, Martinez JA, Hsu CP, Batai K, Saboda K, Thompson PA.

BMJ Open Diabetes Res Care. 2019 Feb 7;7(1):e000613. doi: 10.1136/bmjdrc-2018-000613. eCollection 2019.

6.

The understanding of complex syntax in children with Down syndrome.

Frizelle P, Thompson PA, Duta M, Bishop DVM.

Version 2. Wellcome Open Res. 2019 Feb 28 [revised 2019 Jan 1];3:140. doi: 10.12688/wellcomeopenres.14861.2. eCollection 2018.

7.

The Collaborative Laborist and Midwifery Model: An Accepted and Sustainable Model.

Krolikowski-Ulmer K, Watson TJ, Westhoff EM, Ashmore SL, Thompson PA, Landeen LB.

S D Med. 2018 Dec;71(12):534-537.

PMID:
30835985
8.

Language phenotypes in children with sex chromosome trisomies.

Bishop DVM, Brookman-Byrne A, Gratton N, Gray E, Holt G, Morgan L, Morris S, Paine E, Thornton H, Thompson PA.

Version 2. Wellcome Open Res. 2019 Jan 28 [revised 2019 Jan 1];3:143. doi: 10.12688/wellcomeopenres.14904.2. eCollection 2018.

9.

The Population Pharmacokinetics of High-Dose Methotrexate in Infants with Acute Lymphoblastic Leukemia Highlight the Need for Bedside Individualized Dose Adjustment: A Report from the Children's Oncology Group.

Beechinor RJ, Thompson PA, Hwang MF, Vargo RC, Bomgaars LR, Gerhart JG, Dreyer ZE, Gonzalez D.

Clin Pharmacokinet. 2019 Jul;58(7):899-910. doi: 10.1007/s40262-018-00734-0.

PMID:
30810947
10.

Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development.

Pearson T, Caporaso JG, Yellowhair M, Bokulich NA, Padi M, Roe DJ, Wertheim BC, Linhart M, Martinez JA, Bilagody C, Hornstra H, Alberts DS, Lance P, Thompson PA.

Cancer Med. 2019 Feb;8(2):617-628. doi: 10.1002/cam4.1965. Epub 2019 Jan 16.

11.

Finding the Responders in the Cancer Prevention Trials.

Thompson PA.

J Natl Cancer Inst. 2019 Jan 8. doi: 10.1093/jnci/djy205. [Epub ahead of print] No abstract available.

PMID:
30624679
12.

Fish Oil and Perioperative Bleeding.

Akintoye E, Sethi P, Harris WS, Thompson PA, Marchioli R, Tavazzi L, Latini R, Pretorius M, Brown NJ, Libby P, Mozaffarian D.

Circ Cardiovasc Qual Outcomes. 2018 Nov;11(11):e004584. doi: 10.1161/CIRCOUTCOMES.118.004584.

PMID:
30571332
13.

Uncertainties associated with assessing Ontario uranium miners' exposure to radon daughters.

Navaranjan G, Chambers D, Thompson PA, Do M, Berriault C, Villeneuve PJ, Demers PA.

J Radiol Prot. 2019 Mar;39(1):136-149. doi: 10.1088/1361-6498/aaf1eb. Epub 2018 Nov 19.

PMID:
30524032
14.

A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicities.

Foster JH, Thompson PA, Bernhardt MB, Margolin JF, Hilsenbeck SG, Jo E, Marquez-Do DA, Scheurer ME, Schafer ES.

Cancer Chemother Pharmacol. 2019 Feb;83(2):349-360. doi: 10.1007/s00280-018-3733-2. Epub 2018 Nov 28.

PMID:
30488179
15.

The involvement of microRNA in the pathogenesis of Richter syndrome.

Van Roosbroeck K, Bayraktar R, Calin S, Bloehdorn J, Dragomir MP, Okubo K, Bertilaccio MTS, Zupo S, You MJ, Gaidano G, Rossi D, Chen SS, Chiorazzi N, Thompson PA, Ferrajoli A, Bertoni F, Stilgenbauer S, Keating MJ, Calin GA.

Haematologica. 2019 May;104(5):1004-1015. doi: 10.3324/haematol.2018.203828. Epub 2018 Nov 8.

16.

Stage 2 Registered Report: Variation in neurodevelopmental outcomes in children with sex chromosome trisomies: testing the double hit hypothesis.

Newbury DF, Simpson NH, Thompson PA, Bishop DVM.

Version 2. Wellcome Open Res. 2018 Oct 10 [revised 2018 Jan 1];3:85. doi: 10.12688/wellcomeopenres.14677.2. eCollection 2018.

17.

2018 Scholar's Research Symposium Abstracts.

Zeigler CN, Aaker B, Thompson PA, Kosmenko V.

S D Med. 2018 Sep;71(9):389. No abstract available.

PMID:
30308119
18.

Global patterns of change and variation in sea surface temperature and chlorophyll a.

Dunstan PK, Foster SD, King E, Risbey J, O'Kane TJ, Monselesan D, Hobday AJ, Hartog JR, Thompson PA.

Sci Rep. 2018 Oct 2;8(1):14624. doi: 10.1038/s41598-018-33057-y.

19.

A pilot study of lower doses of ibrutinib in patients with chronic lymphocytic leukemia.

Chen LS, Bose P, Cruz ND, Jiang Y, Wu Q, Thompson PA, Feng S, Kroll MH, Qiao W, Huang X, Jain N, Wierda WG, Keating MJ, Gandhi V.

Blood. 2018 Nov 22;132(21):2249-2259. doi: 10.1182/blood-2018-06-860593. Epub 2018 Sep 25.

PMID:
30254130
20.

Shortened Taper Duration after Implementation of a Standardized Protocol for Iatrogenic Benzodiazepine and Opioid Withdrawal in Pediatric Patients: Results of a Cohort Study.

Vipond JM, Heiberger AL, Thompson PA, Huber JN.

Pediatr Qual Saf. 2018 May 18;3(3):e079. doi: 10.1097/pq9.0000000000000079. eCollection 2018 May-Jun.

21.

Impact of acculturation on breast cancer treatment and survivorship care among Mexican American patients in Texas.

Advani P, Bondy M, Thompson PA, Martínez ME, Nodora JN, Vernon SW, Diamond P, Burnett J, Brewster AM.

J Cancer Surviv. 2018 Oct;12(5):659-668. doi: 10.1007/s11764-018-0703-y. Epub 2018 Jul 25.

22.

Point: Does Chemoimmunotherapy Still Have a Role in CLL? Chemoimmunotherapy With FCR Is Still an Important Option in CLL.

Thompson PA, Tam CS.

Oncology (Williston Park). 2018 Jun;32(6):291-2, 294-6. No abstract available.

23.

Cytomegalovirus reactivation can be a cause of DAT-negative hemolytic anemia in patients with chronic lymphocytic leukemia.

Strati P, Gabutti C, Thompson PA, Kontoyiannis DP, Ferrajoli A.

Leuk Lymphoma. 2019 Feb;60(2):535-537. doi: 10.1080/10428194.2018.1474527. Epub 2018 Jun 18. No abstract available.

PMID:
29911929
24.

Growth in syntactic complexity between four years and adulthood: evidence from a narrative task.

Frizelle P, Thompson PA, McDonald D, Bishop DVM.

J Child Lang. 2018 Sep;45(5):1174-1197. doi: 10.1017/S0305000918000144. Epub 2018 Jun 4.

PMID:
29860949
25.

Serial minimal residual disease (MRD) monitoring during first-line FCR treatment for CLL may direct individualized therapeutic strategies.

Thompson PA, Peterson CB, Strati P, Jorgensen J, Keating MJ, O'Brien SM, Ferrajoli A, Burger JA, Estrov Z, Jain N, Kadia TM, Borthakur G, DiNardo CD, Daver N, Jabbour E, Wierda WG.

Leukemia. 2018 Nov;32(11):2388-2398. doi: 10.1038/s41375-018-0132-y. Epub 2018 Apr 17.

26.

Stage 1 Registered Report: Variation in neurodevelopmental outcomes in children with sex chromosome trisomies: protocol for a test of the double hit hypothesis.

Newbury DF, Simpson NH, Thompson PA, Bishop DVM.

Wellcome Open Res. 2018 Feb 12;3:10. doi: 10.12688/wellcomeopenres.13828.2. eCollection 2018.

27.

Celecoxib use and circulating oxylipins in a colon polyp prevention trial.

Martinez JA, Yang J, Wertheim BC, Roe DJ, Schriewer A, Lance P, Alberts DS, Hammock BD, Thompson PA.

PLoS One. 2018 Apr 26;13(4):e0196398. doi: 10.1371/journal.pone.0196398. eCollection 2018.

28.

Interdisciplinary knowledge exchange across scales in a globally changing marine environment.

McDonald KS, Hobday AJ, Fulton EA, Thompson PA.

Glob Chang Biol. 2018 Jul;24(7):3039-3054. doi: 10.1111/gcb.14168. Epub 2018 May 24. Review.

PMID:
29656423
29.

Reproducible automated breast density measure with no ionizing radiation using fat-water decomposition MRI.

Ding J, Stopeck AT, Gao Y, Marron MT, Wertheim BC, Altbach MI, Galons JP, Roe DJ, Wang F, Maskarinec G, Thomson CA, Thompson PA, Huang C.

J Magn Reson Imaging. 2018 Oct;48(4):971-981. doi: 10.1002/jmri.26041. Epub 2018 Apr 6.

PMID:
29630755
30.

Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition.

Reich SH, Sprengeler PA, Chiang GG, Appleman JR, Chen J, Clarine J, Eam B, Ernst JT, Han Q, Goel VK, Han EZR, Huang V, Hung INJ, Jemison A, Jessen KA, Molter J, Murphy D, Neal M, Parker GS, Shaghafi M, Sperry S, Staunton J, Stumpf CR, Thompson PA, Tran C, Webber SE, Wegerski CJ, Zheng H, Webster KR.

J Med Chem. 2018 Apr 26;61(8):3516-3540. doi: 10.1021/acs.jmedchem.7b01795. Epub 2018 Mar 29.

PMID:
29526098
31.

MRD negativity as a surrogate for PFS in CLL?

Thompson PA.

Blood. 2018 Mar 1;131(9):943-944. doi: 10.1182/blood-2018-01-824177. No abstract available.

32.

Sustained long-lasting responses after lenalidomide discontinuation in patients with chronic lymphocytic leukemia.

Strati P, Ferrajoli A, Wierda WG, Jain N, Thompson PA, O'Brien SM, Rezvani K, Kantarjian HM, Burger JA, Hinojosa CO, Keating MJ, Estrov Z.

Leukemia. 2018 Oct;32(10):2278-2281. doi: 10.1038/s41375-018-0059-3. Epub 2018 Feb 20. No abstract available.

PMID:
29479067
33.

The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.

Shaim H, Estrov Z, Harris D, Hernandez Sanabria M, Liu Z, Ruvolo P, Thompson PA, Ferrajoli A, Daher M, Burger J, Muftuoglu M, Imahashi N, Li L, Liu E, Alsuliman AS, Basar R, Nassif Kerbauy L, Sobieski C, Gokdemir E, Kondo K, Wierda W, Keating M, Shpall EJ, Rezvani K.

Front Immunol. 2018 Jan 15;8:1773. doi: 10.3389/fimmu.2017.01773. eCollection 2017.

34.

Clinical factors associated with physician choice of femoral versus radial access: A real-world experience from a single academic center.

Yee J, Kumar V, Li S, Petraskova T, Pham A, Stys J, Thompson PA, Petrasko M, Stys A, Stys T.

J Interv Cardiol. 2018 Apr;31(2):236-243. doi: 10.1111/joic.12479. Epub 2017 Dec 25.

PMID:
29277921
35.

Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression.

Jabbour E, Düll J, Yilmaz M, Khoury JD, Ravandi F, Jain N, Einsele H, Garcia-Manero G, Konopleva M, Short NJ, Thompson PA, Wierda W, Daver N, Cortes J, O'brien S, Kantarjian H, Topp MS.

Am J Hematol. 2018 Mar;93(3):371-374. doi: 10.1002/ajh.24987. Epub 2017 Dec 23.

36.

The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab.

Jain P, Nogueras González GM, Kanagal-Shamanna R, Rozovski U, Sarwari N, Tam C, Wierda WG, Thompson PA, Jain N, Luthra R, Quesada A, Sanchez-Petitto G, Ferrajoli A, Burger J, Kantarjian H, Cortes J, O'Brien S, Keating MJ, Estrov Z.

Br J Haematol. 2018 Jan;180(1):33-40. doi: 10.1111/bjh.15018. Epub 2017 Nov 21.

37.

Discussion of: "Pretransfer CT scans are frequently performed, but rarely helpful in rural trauma systems".

Thornburg DA, Paulson WE, Thompson PA, Bjordahl PM.

Am J Surg. 2017 Dec;214(6):1065-1066. doi: 10.1016/j.amjsurg.2017.10.007. Epub 2017 Oct 5. No abstract available.

PMID:
29145999
38.

Bruton's tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL).

Thompson PA, Burger JA.

Expert Opin Investig Drugs. 2018 Jan;27(1):31-42. doi: 10.1080/13543784.2018.1404027. Epub 2017 Nov 15. Review.

PMID:
29125406
39.

Measuring language lateralisation with different language tasks: a systematic review.

Bradshaw AR, Thompson PA, Wilson AC, Bishop DVM, Woodhead ZVJ.

PeerJ. 2017 Oct 24;5:e3929. doi: 10.7717/peerj.3929. eCollection 2017.

40.

Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.

Khan M, Siddiqi R, Thompson PA.

Ann Hematol. 2018 Jan;97(1):1-15. doi: 10.1007/s00277-017-3149-9. Epub 2017 Oct 23. Review.

PMID:
29063177
41.

Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway.

Kondo K, Shaim H, Thompson PA, Burger JA, Keating M, Estrov Z, Harris D, Kim E, Ferrajoli A, Daher M, Basar R, Muftuoglu M, Imahashi N, Alsuliman A, Sobieski C, Gokdemir E, Wierda W, Jain N, Liu E, Shpall EJ, Rezvani K.

Leukemia. 2018 Apr;32(4):960-970. doi: 10.1038/leu.2017.304. Epub 2017 Oct 3.

42.

Pretransfer CT scans are frequently performed, but rarely helpful in rural trauma systems.

Thornburg DA, Paulson WE, Thompson PA, Bjordahl PM.

Am J Surg. 2017 Dec;214(6):1061-1064. doi: 10.1016/j.amjsurg.2017.07.037. Epub 2017 Sep 18.

PMID:
28967379
43.

Logical and Methodological Issues Affecting Genetic Studies of Humans Reported in Top Neuroscience Journals.

Grabitz CR, Button KS, Munafò MR, Newbury DF, Pernet CR, Thompson PA, Bishop DVM.

J Cogn Neurosci. 2018 Jan;30(1):25-41. doi: 10.1162/jocn_a_01192. Epub 2017 Sep 26.

PMID:
28949821
44.

Evaluation and comparison of staining patterns of factor XIIIa (AC-1A1), adipophilin and GATA3 in sebaceous neoplasia.

Tjarks BJ, Pownell BR, Evans C, Thompson PA, Kerkvliet AM, Koch MRD, Jassim AD.

J Cutan Pathol. 2018 Jan;45(1):1-7. doi: 10.1111/cup.13037. Epub 2017 Sep 19.

PMID:
28873247
45.

2017 Scholars Day Symposium Abstracts.

Thompson PA, Killian S, Kozmenko V, Zeigler CN.

S D Med. 2017 Sep;70(9):389. No abstract available.

PMID:
28863250
46.

2016 Scholars Day Symposium Abstracts.

Thompson PA, Killian S, Kozmenko V, Zeigler C.

S D Med. 2016 Sep;69(9):389. No abstract available.

PMID:
28806033
47.

A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.

Thomson CA, Chow HHS, Wertheim BC, Roe DJ, Stopeck A, Maskarinec G, Altbach M, Chalasani P, Huang C, Strom MB, Galons JP, Thompson PA.

Breast Cancer Res Treat. 2017 Aug;165(1):97-107. doi: 10.1007/s10549-017-4292-7. Epub 2017 May 30.

48.

Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL).

Jain P, Aoki E, Keating M, Wierda WG, O'Brien S, Gonzalez GN, Ferrajoli A, Jain N, Thompson PA, Jabbour E, Kanagal-Shamanna R, Pierce S, Alousi A, Hosing C, Khouri I, Estrov Z, Cortes J, Kantarjian H, Ravandi F, Kadia TM.

Ann Oncol. 2017 Jul 1;28(7):1554-1559. doi: 10.1093/annonc/mdx163.

49.

Phase 2 of CATALISE: a multinational and multidisciplinary Delphi consensus study of problems with language development: Terminology.

Bishop DVM, Snowling MJ, Thompson PA, Greenhalgh T; and the CATALISE-2 consortium.

J Child Psychol Psychiatry. 2017 Oct;58(10):1068-1080. doi: 10.1111/jcpp.12721. Epub 2017 Mar 30.

50.

Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma.

Short NJ, Kantarjian HM, Ko H, Khoury JD, Ravandi F, Thomas DA, Garcia-Manero G, Khouri M, Cortes JE, Wierda WG, Verstovsek S, Estrov Z, Ferrajoli A, Thompson PA, Pierce S, O'Brien SM, Jabbour E.

Am J Hematol. 2017 Jun;92(6):E114-E117. doi: 10.1002/ajh.24720. Epub 2017 Apr 18. No abstract available.

Supplemental Content

Loading ...
Support Center